Quarterly report pursuant to Section 13 or 15(d)

Cover

v3.24.2.u1
Cover - shares
 6 Months Ended
Jun. 30, 2024
Aug. 07, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2024  
Document Transition Report false  
Entity File Number 001-36672  
Entity Registrant Name KIORA PHARMACEUTICALS, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 98-0443284  
Entity Address, Address Line One 332 Encinitas Blvd.  
Entity Address, Address Line Two Suite 102  
Entity Address, City or Town Encinitas  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 92024  
City Area Code 858  
Local Phone Number 224-9600  
Title of 12(b) Security Common Stock, $0.01 par value  
Trading Symbol KPRX  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   2,970,545
Entity Central Index Key 0001372514  
Document Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q2  
Amendment Flag false